Phio (PHIO) CFO Carson Lisa Cabott Withholds Shares for Taxes

What Happened Carson Lisa Cabott, CFO of Phio Pharmaceuticals (PHIO), had 12,888 shares withheld on September 11, 2026 to satisfy tax withholding related to the vesting of restricted stock units (RSUs). The withholding was recorded at $1.03 per share for a notional value of $13,275. This was a tax-withholding disposition (code F), not an open-market sale — no shares were sold.

Key Details

• Transaction date: 2026-09-11; reported on Form 4 filed 2026-09-15.
• Price per share: $1.03; total disposition value shown: $13,275.
• Transaction code: F (payment of exercise price or tax liability); footnote F1 clarifies shares were withheld by the issuer to satisfy tax withholding on RSU vesting (no sale).
• Footnote F2 indicates the amount includes shares underlying unvested restricted stock units.
• Shares owned after the transaction: not specified in the provided filing.
• Filing timing: the Form 4 was filed four days after the transaction; investors may note the timing relative to the SEC two-business-day reporting expectation.

Context Withholding shares to cover taxes on vested RSUs is a common, administrative transaction and does not reflect an active sale into the market. For retail investors, such tax-withholding dispositions are routine and generally not considered a directional signal about the insider’s view of the company.